Loading…
CIK 0001517796 • 6 13F filings • May 14, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("rangeley-capital-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 4D MOLECULAR THERAPEUTICS IN | COM | $48K | 0.1%Prev: 0.3% | 13,000 SH | Decreased-18,465 SH |
| AKOYA BIOSCIENCES INC | COM | $43K | 0.1% | 33,035 SH | New |
| AMPLIFY ENERGY CORP NEW | COM | $896K | 1.1% | 280,000 SH | New |
| AN2 THERAPEUTICS INC | COM | $69K | 0.1% | 65,000 SH | New |
| ARBUTUS BIOPHARMA CORP | COM | $2.7M | 3.2%Prev: 2.2% | 865,000 SH | Increased+365,000 SH |
| ARES ACQUISITION CORP II | SHS CLASS A | $135K | 0.2% | 11,920 SH | New |
| ARVINAS INC | COM | $5.1M | 6.1%Prev: 2.3% | 694,800 SH | Increased+470,810 SH |
| ATEA PHARMACEUTICALS INC | COM | $191K | 0.2%Prev: 0.2% | 53,000 SH | Decreased+6,500 SH |
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | $521K | 0.6%Prev: 1.0% | 75,000 SH | Decreased-157,260 SH |
| BLUEPRINT MEDICINES CORP | COM | $641K | 0.8% | 5,000 SH | New |
| BRIDGEBIO PHARMA INC | COM | $216K | 0.3% | 5,000 SH | New |
| BURFORD CAP LTD | ORD SHS | $727K | 0.9% | 51,000 SH | New |
| CABALETTA BIO INC | COM | $24K | 0.0% | 16,000 SH | New |
| CADIZ INC | COM NEW | $1.4M | 1.7%Prev: 0.2% | 469,000 SH | Increased+419,000 SH |
| CALUMET INC | COM | $5.0M | 6.0%Prev: 1.8% | 319,000 SH | Increased+266,000 SH |
| CARGO THERAPEUTICS INC | COM | $172K | 0.2% | 41,851 SH | New |
| CHARTER COMMUNICATIONS INC N | CL A | $3.7M | 4.4% | 9,000 SH | New |
| CORE SCIENTIFIC INC NEW | *W EXP 01/23/202 | $2.5M | 3.0%Prev: 0.2% | 146,200 SH | Increased+119,000 SH |
| CVR PARTNERS LP | COM | $1.3M | 1.6% | 15,000 SH | New |
| D MARKET ELECTR SVCS & TRADI | SPONSORED ADS | $540K | 0.6%Prev: 0.5% | 200,000 SH | Increased |
| DELEK US HLDGS INC NEW | COM | $6.6M | 7.9%Prev: 2.6% | 313,000 SH | Increased+253,000 SH |
| ELEVATION ONCOLOGY INC | COM | $332K | 0.4% | 905,289 SH | New |
| ESSA PHARMA INC | COM NEW | $289K | 0.3% | 170,000 SH | New |
| FULL HSE RESORTS INC | COM | $3.2M | 3.9%Prev: 2.0% | 882,426 SH | Increased-33,152 SH |
| GENESIS ENERGY L P | UNIT LTD PARTN | $1.3M | 1.5% | 74,000 SH | New |
| GSR III ACQUISITION CORP | CL A | $119K | 0.1% | 11,000 SH | New |
| HILLEVAX INC | COM | $306K | 0.4% | 153,790 SH | New |
| INTERNATIONAL GAME TECHNOLOG | SHS USD | $269K | 0.3% | 17,000 SH | New |
| ITEOS THERAPEUTICS INC | COM | $3.0M | 3.6% | 302,080 SH | New |
| KELLANOVA | COM | $239K | 0.3% | 3,000 SH | New |
| KEROS THERAPEUTICS INC | COM | $3.8M | 4.5%Prev: 0.6% | 285,400 SH | Increased+231,000 SH |
| KURA ONCOLOGY INC | COM | $669K | 0.8%Prev: 0.8% | 116,000 SH | Decreased+14,780 SH |
| LAVA THERAPEUTICS NV | SHS | $36K | 0.0% | 27,073 SH | New |
| LENSAR INC | COM | $659K | 0.8%Prev: 0.4% | 50,000 SH | Increased-13,000 SH |
| MACROGENICS INC | COM | $33K | 0.0%Prev: 0.1% | 27,000 SH | Decreased+5,500 SH |
| MEI PHARMA INC | COM | $25K | 0.0% | 10,000 SH | New |
| MOUNTAIN LAKE ACQUISITION CO | RIGHT 11/15/2028 | $308K | 0.4% | 30,000 SH | New |
| MURAL ONCOLOGY PUB LTD CO | ORD SHS | $115K | 0.1% | 46,513 SH | New |
| NATURAL RESOURCE PARTNERS L | COM UNIT LTD PAR | $1.2M | 1.4% | 12,100 SH | New |
| NEBIUS GROUP N.V. | SHS CLASS A | $216K | 0.3% | 3,900 SH | New |
| NET LEASE OFFICE PROPERTIES | COM | $2.3M | 2.7%Prev: 1.3% | 70,000 SH | Increased-44,870 SH |
| NOVABAY PHARMACEUTICALS INC | COM NEW | $19K | 0.0% | 33,210 SH | New |
| NUVATION BIO INC | COM CL A | $25K | 0.0% | 13,000 SH | New |
| ONKURE THERAPEUTICS INC | COM CL A | $71K | 0.1%Prev: 0.4% | 29,902 SH | Decreased-65,098 SH |
| PEPGEN INC | COM | $39K | 0.0%Prev: 0.1% | 35,000 SH | Decreased-33,096 SH |
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | $212K | 0.3% | 20,000 SH | New |
| PLIANT THERAPEUTICS INC | COM | $70K | 0.1%Prev: 0.3% | 60,220 SH | Decreased-164,780 SH |
| PROTHENA CORP PLC | SHS | $4.3M | 5.2%Prev: 4.2% | 715,367 SH | Decreased+265,907 SH |
| REPARE THERAPEUTICS INC | COM | $494K | 0.6% | 355,292 SH | New |
| SABLE OFFSHORE CORP | COM SHS | $550K | 0.7%Prev: 0.3% | 25,000 SH | Increased+6,000 SH |
| SAGE THERAPEUTICS INC | COM | $6.7M | 7.9% | 730,000 SH | New |
| SEAPORT ENTMT GROUP INC | COMMON STOCK | $2.9M | 3.5%Prev: 3.2% | 158,000 SH | Decreased+4,483 SH |
| SEER INC | COM CL A | $21K | 0.0%Prev: 0.3% | 10,000 SH | Decreased-174,302 SH |
| SEPTERNA INC | COM | $619K | 0.7%Prev: 0.9% | 58,605 SH | Decreased+18,805 SH |
| SILVERBOX CORP IV | SHS CL A | $110K | 0.1% | 10,000 SH | New |
| SITE CTRS CORP | COM | $452K | 0.5%Prev: 0.1% | 40,001 SH | Increased+26,001 SH |
| SKECHERS U S A INC | CL A | $2.3M | 2.7% | 36,000 SH | New |
| SOHO HOUSE & CO INC | COM CL A | $203K | 0.2% | 27,600 SH | New |
| STAR HLDGS | SHS BEN INT | $1.3M | 1.6%Prev: 2.0% | 172,000 SH | Decreased-102,072 SH |
| SURGERY PARTNERS INC | COM | $3.7M | 4.4% | 166,060 SH | New |
| SWK HLDGS CORP | COM NEW | $604K | 0.7%Prev: 1.0% | 41,000 SH | Decreased-22,000 SH |
| SYNLOGIC INC | COM NEW | $17K | 0.0% | 13,597 SH | New |
| THERATECHNOLOGIES INC | COM NEW | $118K | 0.1% | 50,000 SH | New |
| THERAVANCE BIOPHARMA INC | COM | $372K | 0.4%Prev: 1.6% | 33,729 SH | Decreased-69,271 SH |
| THIRD HARMONIC BIO INC | COM | $1.6M | 1.9% | 290,000 SH | New |
| TRILOGY METALS INC NEW | COM | $117K | 0.1%Prev: 0.3% | 87,000 SH | Decreased |
| VERVE THERAPEUTICS INC | COM | $696K | 0.8% | 62,000 SH | New |
| VIGIL NEUROSCIENCE INC | COM | $539K | 0.6% | 67,800 SH | New |
| VIVID SEATS INC | COM CL A | $42K | 0.1% | 25,000 SH | New |
| WALGREENS BOOTS ALLIANCE INC | COM | $1.2M | 1.4% | 102,000 SH | New |
| WIDEOPENWEST INC | COM | $3.4M | 4.1% | 849,000 SH | New |
| ZURA BIO LTD | CLASS A ORD SHS | $22K | 0.0% | 21,000 SH | New |
| 13F-HR |
| 0001892688-26-000133 |
| $109.5M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000919574-25-004826 | $83.8M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001892688-26-000089 | $102.9M | View |
| May 14, 2025 | Q1 2025 | 13F-HR | 0000919574-25-003019 | $93.4M | View |